Thanks for the Prima link in the Australian as well.
My gut feel after Cephalon's play for Chemgenex still stands, though even more so now: Prima Biomed will be firmly on the takeover radar, with the most likely predator being Dendreon.
No other monolith in the biotech sector would be more cognisant of Prima Biomed's patented technology than Dendreon.
Not that I wish it to happen, but is there a better fit than Prima Biomed/Dendreon?
A marriage made in heaven.
the next must-buy biotech is anyone's guess, page-11
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 73996 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 836970 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |